Signet Financial Management’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-93
Closed -$19K – 880
2021
Q4
$19K Buy
+93
New +$19.2K ﹤0.01% 893
2018
Q4
– Sell
-20
Closed -$4K – 588
2018
Q3
$4K Buy
20
+15
+300% +$3.04K ﹤0.01% 825
2018
Q2
$1K Buy
+5
New +$639 ﹤0.01% 900

Other funds holding MED

Signet Financial Management's MED Position: Q1 2022 in Review

Signet Financial Management sold out of Medifast (MED) in Q1 2022, closing a stake of 93 shares — an estimated $19K sold.

Signet Financial Management first reported a position in MED in Q2 2018 and held it in 3 quarters. The position peaked at $19K in Q4 2021. 288 funds tracked by Wall St. Rank hold MED as of Q1 2022.

  • Signet Financial Management reported no remaining Medifast position as of Q1 2022 after selling out during the quarter.
  • Signet Financial Management sold 93 Medifast shares in Q1 2022, an estimated $19K.
  • Signet Financial Management first reported a position in Medifast in Q2 2018 and held it in 3 quarters.
  • Signet Financial Management's Medifast position peaked at $19K in Q4 2021.
  • 288 funds tracked by Wall St. Rank held Medifast as of Q1 2022.

Based on Signet Financial Management's 13F filing for Q1 2022, filed 13 May 2022.